BL

GoComet launches Advanced Predictive ETA, GoPlan & Proactive Upload: Step into the future

Retrieved on: 
Wednesday, September 14, 2022
ETA, Proactivity, Risk, ETAS, Solution, BL, Goplans, Software as a service, Customer advisory council, Cassette tape, Cargo, Vectors in gene therapy

SINGAPORE, Sept. 14, 2022 /PRNewswire/ -- GoComet, a leading multi-modal logistics and transportation company, has launched a breakthrough product, 'GoPlan', one of the first data-backed dispatch planning solutions that will allow shippers to plan their freight delivery schedules with better predictability using one of the the industry's best estimate lead time benchmarking indexes. It will help shippers promise realistic delivery ETAs to end consignees when shipping containers worldwide. The company aims to solve one of the biggest challenges prevailing in the supply chain industry – Inaccurate Carrier ETAs. Alongside, it chooses the best performing carrier that is economical, effective and helps in delivering as planned with less risk for customers.  

Key Points: 
  • The company aims to solve one of the biggest challenges prevailing in the supply chain industry Inaccurate Carrier ETAs.
  • Alongside, it chooses the best performing carrier that is economical, effective and helps in delivering as planned with less risk for customers.
  • In addition to the new product, GoComet announced a major platform upgrade , because getting notified after a shipment gets delayed is a thing of the past.
  • Trusted by 200+ global brands across 35 countries, GoComet is currently headquartered in Singapore and has a presence in Southeast Asia, the US and Europe.

Bilibili Comics announces partnership with Anime-Planet

Retrieved on: 
Wednesday, July 27, 2022
Animation, Industry, Instagram, Twitter, Martial arts, GL, Partnership, Oleśnica, Multimedia, Science, BL, Funimation, Netflix, Book, Entertainment

SINGAPORE, July 27, 2022 /PRNewswire/ --Bilibili Comics is proud to announce a partnership with Anime-Planet, providing free chapters of manga and webtoons to Anime-Planet's online reading portal.

Key Points: 
  • SINGAPORE, July 27, 2022 /PRNewswire/ --Bilibili Comics is proud to announce a partnership with Anime-Planet, providing free chapters of manga and webtoons to Anime-Planet's online reading portal.
  • In addition, Bilibili Comics has added Anime-Planet's community ratings to their pages as part of a new third-party scoring feature.
  • A spokesman from Bilibili Comics said, "We are very optimistic about the cooperation with Anime-Planet, which will allow Bilibili Comics to connect with more comic users.
  • Kim Cameron, Anime-Planet's founder, said: "We are thrilled to have this opportunity to partner with Bilibili Comics.

The Israel Ministry of Defense will begin testing a robotic unmanned vehicle (M-RCV Medium Robotic Combat Vehicle), developed by the Ministry's Directorate of Defense Research and Development (DDR&D), the Tank and APC Directorate, and Israeli security ind

Retrieved on: 
Monday, June 13, 2022
Elbit Systems, Bronco All Terrain Tracked Carrier, APC, BL, Defense, Foresight, IAI, Tank, Ministry, DDR, Exhibition, TEL, Rafael Advanced Defense Systems, Communication Troops of the Ministry of Defense of the Soviet Union, Unmanned aerial vehicle, Satellite navigation device

TEL AVIV, Israel, June 13, 2022 /PRNewswire/ -- The robotic combat vehicle will be unveiled today at Elbit Systems' pavilion at the Eurosatory Defense and Security Exhibition.

Key Points: 
  • TEL AVIV, Israel, June 13, 2022 /PRNewswire/ -- The robotic combat vehicle will be unveiled today at Elbit Systems' pavilion at the Eurosatory Defense and Security Exhibition.
  • The vehicle also features a capsuled drone for forward reconnaissance missions, and a passive sensing kit developed by Elbit Systems and Foresight.
  • The vehicle will also incorporate sights, an IAI missile launcher, and Rafael Advanced Defense Systems' 'Spike' missiles.
  • It is operational during the day and night in all-weather scenarios, while emphasizing operational effectiveness, simplicity, minimum operator intervention, and integration into heterogeneous unmanned arrays.

BlackLine Wins TrustRadius Top Rated 2022 Awards for Accounting, Financial Close and Accounts Receivable Automation

Retrieved on: 
Wednesday, May 11, 2022
Communication, Leisure, SOX, Defense Finance and Accounting Service, G2, Blackline (software company), Telecommunication, Research, Review, Automation, Organization, Bird Education Society for Travel & Tourism, Travel, Compliance, ERP, ERPs, Efficiency, Computer hardware, LOS, BL, Responsibility assignment matrix, Solution, Technology, VP, Consultant, Awareness, Automotive industry, AR, Multimedia, Mobile phone, Bank, Online shopping, Retail, Electronics, San Francisco Bay, Microsoft Excel, Accounting

LOS ANGELES, May 11, 2022  /PRNewswire/ -- BlackLine, Inc. (Nasdaq: BL) has been recognized as a leader once again, earning 'Top Rated 2022' awards in the Accounting, Financial Close and Accounts Receivable (AR) categories from TrustRadius, a leading software peer review platform that has become a B2B industry standard, providing unbiased recognition of technology products based entirely on customer feedback. 

Key Points: 
  • "Earning multiple Top Rated awards is testament to BlackLine's leadership position in both financial close and accounts receivable automation,"said Megan Headley, VP of Research at TrustRadius.
  • "Reviewers on TrustRadius consistently highlight the convenience of having a centralized platform for financial automation, along with BlackLine's stellar customer support."
  • Senior Accountant (Telecommunications; 501-1,000 employees)
    " Automation, transparency, accuracy and controllable - [BlackLine] saves us tremendous time during the closing period, more accuracy, transparency and control.
  • The three Top Rated awards come on the heels of BlackLine earning '2022 Best of Finance Software' awards from TrustRadius earlier this year for 'Best Relationship' and 'Best Feature Set'.

Iveric Bio Announces Presentation of Post-Hoc Analysis from GATHER1 Clinical Trial of Zimura® in Patients with Geographic Atrophy

Retrieved on: 
Wednesday, May 4, 2022
General Health, Health, Science, Other Science, Research, U.S. Securities and Exchange Commission, Forward-looking statement, Fovea, Private Securities Litigation Reform Act, EMA, Nasdaq, European Medicines Agency, C5a, Company, Complement component 5, Food, Geographic atrophy, Patient, Security (finance), Clinical trial, FDA, Retina, MAC, Regulation of tobacco by the U.S. Food and Drug Administration, ISEE, MD, Multimedia, Marketing, Retinal, Cell death, BL, C5, Research, Doctor of Pharmacy, Retinal pigment epithelium, Epithelium, Pharmaceutical industry, Ophthalmology

In-line with the overall results of GATHER1, a reduction of GA lesion growth in patients receiving Zimura as compared to patients receiving sham was consistently observed across all baseline distances from the foveal center.

Key Points: 
  • In-line with the overall results of GATHER1, a reduction of GA lesion growth in patients receiving Zimura as compared to patients receiving sham was consistently observed across all baseline distances from the foveal center.
  • No additional safety analysis was performed as part of the post-hoc analysis.
  • The Company previously announced that in GATHER1, Zimura (avacincaptad pegol) met its pre-specified primary efficacy endpoint with statistical significance.
  • This potential mechanism is the rationale for Zimura as a potential therapy for geographic atrophy.

TRUSTRADIUS NAMES BLACKLINE 'BEST OF' IN FINANCIAL CLOSE AUTOMATION, AGAIN

Retrieved on: 
Wednesday, January 12, 2022
Civic, Leisure, Research, Customer support, Technology, Automotive industry, G2, Blackline (software company), Organization, Usability, BL, Travel, Data management, Paper, Solution, LOS, Review, Automation, VP, Marketing, Accounting, Environment, CFO, Social organization, Multimedia, ROI, Communication, ERPs, Paper Forest (In the Afterglow of Rapture), Awareness, Mobile phone, Retail, Online shopping, Electronics, Microsoft Excel, San Francisco Bay

LOS ANGELES, Jan. 12, 2022 /PRNewswire/ -- BlackLine, Inc. (Nasdaq: BL) has taken first place in two financial close categories ('Best Relationship' and 'Best Feature Set') in the second annual 'Best of Finance Software Awards' presented by TrustRadius, a leading B2B software peer reviews platform.  

Key Points: 
  • "Earning awards for both 'Best Feature Set' and 'Best Relationship' are testament to BlackLine's leadership position in financial close automation," said Megan Headley, VP of Research at TrustRadius.
  • Here's what users across multiple industries and from various company sizes are saying about BlackLine at TrustRadius.com:
    "Finally, a solution that works for me!
  • This announcement marks the second consecutive year BlackLine has been recognized by TrustRadius with 'Best of Finance Software Awards', having swept all of the 2021 financial close categories (Customer Support, Usability and Feature Set).
  • The company is the pioneer of the cloud financial close market and recognized as the leader by customers at leading end-user review sites including Gartner Peer Insights, G2 and TrustRadius.

LumiThera, Inc. Announces Creation of a Light-based Theranostic Approach to Treat Ocular Disease with Acquisition of Diopsys, Inc.

Retrieved on: 
Thursday, November 11, 2021
Population, Vision, ITT, R, BL, Eye, European Union, CEO, Disease, Ageing, Technology, PBM, CE marking, Food, Machine learning, Union, ERG, FDA, AMD, Severe cognitive impairment, Degenerative disease, Acquisition, CS, Evoked potential, Electroretinography, Diagnosis, Visual acuity, Physician, Diospi Suyana, Prevalence, Patient, Month, Letter, VEP, EU, Retina, Medical device, Pharmaceutical industry, Medical imaging

The acquisition should provide a complementary diagnosis and monitoring platform to LumiThera's leading treatment platform using Photobiomodulation (PBM) for ocular disease and damage.

Key Points: 
  • The acquisition should provide a complementary diagnosis and monitoring platform to LumiThera's leading treatment platform using Photobiomodulation (PBM) for ocular disease and damage.
  • Previously, LumiThera reported the U.S. LIGHTSITE III dry Age-related Macular Degeneration (AMD) trial fully enrolled 100 subjects in 1Q of 2021.
  • The LIGHTSITE III trial is continuing to move forward with the 13-month efficacy timepoint for all patients anticipated in 1Q of 2022.
  • The company is commercializing the office based Valeda Light Delivery System to be used by eyecare providers as medical treatments.

LumiThera, Inc. Announces Creation of a Light-based Theranostic Approach to Treat Ocular Disease with Acquisition of Diopsys, Inc.

Retrieved on: 
Thursday, November 11, 2021
Population, Vision, ITT, R, BL, Eye, European Union, CEO, Disease, Ageing, Technology, PBM, CE marking, Food, Machine learning, Union, ERG, FDA, AMD, Severe cognitive impairment, Degenerative disease, Acquisition, CS, Evoked potential, Electroretinography, Diagnosis, Visual acuity, Physician, Diospi Suyana, Prevalence, Patient, Month, Letter, VEP, EU, Retina, Medical device, Pharmaceutical industry, Medical imaging

The acquisition should provide a complementary diagnosis and monitoring platform to LumiThera's leading treatment platform using Photobiomodulation (PBM) for ocular disease and damage.

Key Points: 
  • The acquisition should provide a complementary diagnosis and monitoring platform to LumiThera's leading treatment platform using Photobiomodulation (PBM) for ocular disease and damage.
  • Previously, LumiThera reported the U.S. LIGHTSITE III dry Age-related Macular Degeneration (AMD) trial fully enrolled 100 subjects in 1Q of 2021.
  • The LIGHTSITE III trial is continuing to move forward with the 13-month efficacy timepoint for all patients anticipated in 1Q of 2022.
  • The company is commercializing the office based Valeda Light Delivery System to be used by eyecare providers as medical treatments.

Late-Breaking Data at the International Headache Society & European Headache Federation Joint Congress 2021 Showed AJOVY® (fremanezumab-vfrm) Injection Reduced More Monthly Migraine Days in a Network Meta-Analysis Study with Atogepant and Rimegepant

Retrieved on: 
Wednesday, September 8, 2021
Science, Biotechnology, Research, Pharmaceutical, Medical Supplies, General Health, Health, Clinical Trials

For 12 weeks of double-blind treatment in FOCUS, 838 eligible patients were randomized one-to-one-to-one to quarterly fremanezumab, monthly fremanezumab or matched placebo.

Key Points: 
  • For 12 weeks of double-blind treatment in FOCUS, 838 eligible patients were randomized one-to-one-to-one to quarterly fremanezumab, monthly fremanezumab or matched placebo.
  • Change from baseline in monthly average maximum number of consecutive MFD was evaluated.
  • At baseline, mean numbers of maximum consecutive MFD were comparable across treatment groups (quarterly fremanezumab, 5.1 days [2.84]; monthly fremanezumab, 5.1 days [3.11]; placebo, 4.8 days [3.03]).
  • In all three studies, patients with CM or EM were randomized one-to-one-to-one to quarterly fremanezumab, monthly fremanezumab or matched placebo.

Sumo Logic Helps Fintechs Modernize Banking with Continuous Intelligence

Retrieved on: 
Wednesday, February 17, 2021
Articles, Information technology, Computing, System administration, Information technology management, Network management, Sumo Logic, Suggested Upper Merged Ontology, Logic, BL

We rely on Sumo Logic to provide the continuous intelligence needed across both operations and security, so customers can confidently move data between disparate systems quickly and securely."

Key Points: 
  • We rely on Sumo Logic to provide the continuous intelligence needed across both operations and security, so customers can confidently move data between disparate systems quickly and securely."
  • Sumo Logics Continuous Intelligence Platform addresses the challenges fintechs face by unifying all machine datalogs, events, and performance metricsacross on-premises, cloud-hosted and hybrid environments.
  • The Sumo Logic Continuous Intelligence Platform automates the collection, ingestion, and analysis of application, infrastructure, security, and IoT data to derive actionable insights within seconds.
  • Sumo Logic is a trademark or registered trademark of Sumo Logic in the United States and in foreign countries.